Most Frequent Preferred Terms for serious and non-serious reports following Synflorix in VAERS with normalized frequency per 100,000 patients.
收藏数据链接：
官方服务：
资源简介：
Most Frequent Preferred Terms for serious and non-serious reports following Synflorix in VAERS with normalized frequency per 100,000 patients.
创建时间：
2026-01-12
